Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma

NCT06785415 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Multiple Myeloma

Interventions

PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Scan
PROCEDURE: Chest Radiography
PROCEDURE: Computed Tomography
BIOLOGICAL: Daratumumab
DRUG: Dexamethasone
BIOLOGICAL: Elotuzumab
DRUG: Iberdomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography

Sponsor

Mayo Clinic